In the pivotal Phase III trials, a number of subgroups were analyzed based on patient- and disease-related parameters, including age, sex, race, ECOG performance status, location of primary tumor, prior adjuvant therapy, number of metastatic sites, tumor burden, and prior radiotherapy.1,2,5,6 more.
I cant really gove you an answer,but what I can give you is a way to a solution, that is you have to find the anglde that you relate to or peaks your interest. A good paper is one that people get drawn into because it reaches them ln some way.As for me WW11 to me, I think of the holocaust and the effect it had on the survivors, their families and those who stood by and did nothing until it was too late.